Artemis Medicare Services Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹306 Cr +13.3% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
AM

Artemis Medicare Services Ltd

Q4 FY26Healthcare Services

Artemis Medicare Services Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹274Cr
+16.6% YoY
+2.6% QoQ
Net profit
₹30Cr
+30.4% YoY
+30.4% QoQ
Margin
18%
+3 pp YoY
+2 pp QoQ
Price₹326
Market cap₹5.1K Cr
P/E44.2

The short version

Artemis Medicare anticipates a 15% to 17% annual revenue growth from flagship hospitals over the next 3-4 years. Revenue growth of 15% to 17% year-on-year expected from flagship hospitals over next 3-4 years (Rudra Acharjee, Pg 16).

From Artemis Medicare Services Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Artemis Medicare anticipates a 15% to 17% annual revenue growth from flagship hospitals over the next 3-4 years.
  • Expansion plans include increasing operational beds from 544 currently and adding 200 beds at Raipur, targeting 2,000+ beds by 2029.
  • International patient revenue is expected to remain around 30-31%, with ongoing geographic diversification.
  • The Gurgaon facility aims to increase occupancy from ~64.6% to 70-75% by Q2 FY27, supporting revenue growth.
  • A 15% overall increase in top line is budgeted for both domestic and international patients, with price hikes of about 15%.

2 more points from Artemis Medicare Services Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Artemis Medicare Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Gurgaon: Potential addition of 100 beds; plan to open 50 beds once 70% occupancy is achieved, followed by another 50 beds; capital allocation focusing on extension and maturity of existing towers.
  • New South Delhi & Raipur facilities:
  • Raipur: 650-bed facility planned in two phases (450 beds and 200 beds); capex around INR 500 crores (INR 350 crores for first 450 beds, INR 150-160 crores for next 200 beds); interiors and equipment included; Raipur operational beds to reach 300 within two quarters post-launch.
  • South Delhi: 650 beds planned; capex to start post-FY27 with major expenses from FY28 onwards; includes interiors and equipment, land/building owned by trust.
  • Additional capex of INR 100 crores planned in FY27 for Gurgaon replacement and fitting for Raipur.

2 more points from Artemis Medicare Services Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Artemis Medicare Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Artemis Medicare Services Ltd said on order book & pipeline — free account, 30 seconds.

Artemis Medicare Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Artemis Medicare Services Ltd Q4 FY26 results — key figures

Artemis Medicare Services Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue274235+16.6%267+2.6%
Operating profit (EBITDA)5036+38.9%44+13.6%
Operating margin18%15%+3 pp16%+2 pp
Profit before tax3929+34.5%30+30%
Net profit (PAT)3023+30.4%23+30.4%
EPS (₹)1.871.69+10.7%1.42+31.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹306 Cr, net profit ₹31 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Suven Life Sciences (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Artemis Medicare Services Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Artemis Medicare Services Ltd Q4 FY26 results?

Artemis Medicare anticipates a 15% to 17% annual revenue growth from flagship hospitals over the next 3-4 years. Revenue growth of 15% to 17% year-on-year expected from flagship hospitals over next 3-4 years (Rudra Acharjee, Pg 16).

What is Artemis Medicare Services Ltd share price analysis?

Artemis Medicare Services Ltd currently shows a neutral. The stock trades at a P/E of 44.2 with a market cap of ₹5,100 Cr. Investors should review the full earnings analysis for detailed insights.

Is Artemis Medicare Services Ltd planning capital expenditure?

Gurgaon: Potential addition of 100 beds; plan to open 50 beds once 70% occupancy is achieved, followed by another 50 beds; capital allocation focusing on extension and maturity of existing towers.

Keep Artemis Medicare Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.